US2021139404A1PendingUtilityA1
Compounds and synthetic methods for the preparation of retinoid x receptor-specific retinoids
Est. expiryNov 17, 2037(~11.3 yrs left)· nominal 20-yr term from priority
C07C 2602/10C07C 51/09C07C 45/29C07C 29/44C07C 29/32C07C 2601/02C07C 67/343C07C 57/50C07F 5/027C07C 2601/14C07C 311/08A61P 25/00C07B 2200/07C07C 51/255A61K 31/198C07C 33/36C07C 33/38C07C 2601/10C07C 31/1333C07C 31/137C07C 29/86A61K 31/192
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are compounds useful for the preparation of compounds that have retinoid-like biological activity. Also provided herein are processes for the preparation of compounds that have retinoid-like biological activity.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of synthesizing a compound of Formula II
by treating a compound of Formula I
wherein R 1 is C 1-20 -alkyl; C 1-20 -alkyl substituted with one or more substituents independently selected from —NH 2 , —NH(C 1-10 -alkyl), —N(C 1-10 -alkyl)(C 1-10 -alkyl), —OH, halogen, —C 1-10 -alkyl, —C 1-10 -haloalkyl, —O—(C 1-10 -alkyl), or —O—(C 1-10 -haloalkyl); C 1-20 -alkenyl; C 1-20 -alkenyl substituted with one or more substituents independently selected from —NH 2 , —NH(C 1-10 -alkyl), —N(C 1-10 -alkyl)(C 1-10 -alkyl), —OH, halogen, —C 1-10 -alkyl, —O—(C 1-10 -alkyl), or —O—(C 1-10 -haloalkyl); C 6-14 -aryl; or C 6-14 -aryl substituted with one or more substituents independently selected from —NH 2 , —NH(C 1-10 -alkyl), —N(C 1-10 -alkyl)(C 1-10 -alkyl), —OH, halogen, —C 1-10 -alkyl, —O—(C 1-10 -alkyl), or —O—(C 1-10 -haloalkyl),
or a salt, hydrate, or solvate thereof,
with potassium tert-butoxide (KOt-Bu) forming a mixture, and then adding to the mixture a Compound 32, having the structure
or a salt, hydrate, or solvate thereof,
such that the compound of Formula II, or a salt, hydrate, or solvate thereof, is prepared.
2 . The method of claim 1 , wherein R 1 is C 4-20 -alkyl, C 1-20 -alkenyl, or C 6-16 -aryl.
3 . The method of claim 1 , wherein the compound of Formula II is a Compound 37, having the structure
and the compound of Formula I is Compound 12, having the structure
such that Compound 37 or a salt, hydrate, or solvate thereof, is prepared.
4 . The method of claim 1 , wherein the compound of Formula II is a compound of Formula III
and the Compound 32 is Compound 11, having the structure
such that the compound of Formula III, or a salt, hydrate, or solvate thereof, is prepared.
5 . The method of claim 4 , wherein R 1 is C 4-20 -alkyl, C 1-20 -alkenyl, or C 6-16 -aryl.
6 . The method of claim 4 , wherein the compound of Formula III is Compound 13, having the structure
and the compound of Formula I is Compound 12, having the structure
such that Compound 13, or a salt, hydrate, or solvate thereof, is prepared.
7 . The method of claim 1 , wherein treatment of the compound of Formula I with KOt-Bu is carried out under an inert atmosphere.
8 . The method of claim 1 , wherein the added Compound 32 is in a tetrahydrofuran or ether solvent.
9 . The method of claim 1 , further comprising quenching the reaction with water.
10 . The method of claim 9 , further comprising extracting the compound of Formula II with ethyl acetate.
11 . A method of making Compound 38,
or a pharmaceutically acceptable salt thereof,
comprising a synthetic process of preparing intermediate compound 37, having the structure
or a salt, hydrate, or solvate thereof,
by treating compound 12, having the structure
or a salt, hydrate, or solvate thereof,
with potassium tert-butoxide (KOt-Bu), and then adding to this mixture Compound 32, having the structure
such that the intermediate compound 37, or a salt, hydrate, or solvate thereof, is prepared.
12 . The method of claim 11 , wherein Compound 38 has an enantiomeric excess of Compound A,
of at least about 98.0%.
13 . The method of claim 11 , wherein treatment of compound 12 with KOt-Bu is carried out under an inert atmosphere.
14 . The method of claim 11 , wherein the added Compound 32 is in a tetrahydrofuran or ether solvent.
15 . The method of claim 11 , further comprising quenching the reaction with water.
16 . The method of claim 15 , further comprising extracting Compound 37 with ethyl acetate.Join the waitlist — get patent alerts
Track US2021139404A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.